December 31st, 2019

Peter H. Addy PhD – Salvia: Research and Therapeutic Use

News on December 31, 2019 from | Psychedelics Today

In this episode, Joe interviews Dr. Peter Addy, Licensed Mental Health Counselor out of Washington. In the show, they talk about the research and therapeutic use of Salvia.

3 Key Points:

  1. Salvinorin A is the active molecule that causes the psychedelic experiential reports, although there are at least a dozen unique compounds in the Salvia plant.
  2. In a recreational setting, Salvia is usually smoked, but in the Mazatec culture, they do not smoke it, they use a sublingual method.
  3. The clinical applications of Salvia are tricky right now. It’s not easy to get funding for psychedelic research.

Support the show

Navigating Psychedelics

Show Notes About Peter

  • Peter helped found the Yale Psychedelic Speaker Series
    • The main goal was to normalize talking about psychedelic research as research
  • Peter joined the pharmacology lab for his post doctoral research on Salvia
    • The team was mainly studying THC but were also studying Ketamine
    • He wanted to bring in MDMA and Psilocybin research
  • Peter attended The Institute of Transpersonal Psychology
    • As a psychologist, Peter focused heavily on feedback and experience

Transpersonal Psychology

Comments & Reviews

Your email address will not be published. Required fields are marked *


nineteen + 13 =

This site uses Akismet to reduce spam. Learn how your comment data is processed.